Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab.

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Abstract Text:

Shinichi Kako,Yoshinobu Kanda,Kumi Oshima,Nahoko Nishimoto,Hiroyuki Sato,Takuro Watanabe,Noriko Hosoya,Toru Motokura,Shigesaburo Miyakoshi,Shuichi Taniguchi,Aki Kamijo,Koki Takahashi,Shigeru Chiba,Mineo Kurokawa,

Hemolytic anemia and pure red cell aplasia (PRCA) after allogeneic hematopoietic stem cell transplantation (HSCT) have been reported to be mainly related to ABO-incompatibility between donor and recipient. Autoimmune hemolytic anemia (AIHA) without ABO-incompatibility has been also reported after allogeneic HSCT, especially with T-cell depletion. However, optimal management of AIHA or PRCA remains unclear. A 54-year-old male with myelodysplastic syndrome (MDS) underwent haploidentical human leukocyte antigen-mismatched HSCT using in vivo alemtuzumab and developed AIHA and PRCA simultaneously 15 months after transplantation, following the administration of cidofovir and probenecid for persistent cytomegalovirus (CMV) antigenemia and retinitis. AIHA was successfully treated with rituximab, and subsequently PRCA with cyclosporine without relapse of MDS or recurrence of CMV infection. The clinical course suggested that AIHA was mainly caused by humoral immune response, while PRCA was mainly caused by cell-mediated immune response in this patient, although these immune responses might be related to each other. Am. J. Hematol., 2008. (c) 2007 Wiley-Liss, Inc.

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Publishing Authors By Initials

S Kako,Y Kanda,K Oshima,N Nishimoto,H Sato,T Watanabe,N Hosoya,T Motokura,S Miyakoshi,S Taniguchi,A Kamijo,K Takahashi,S Chiba,M Kurokawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: American journal of hematology

VOLUME: 83

Page Numbers: 247-9

Journal Abbreviation: Am. J. Hematol.

ISSN: 0361-8609

DAY: 4

MONTH: Mar

YEAR: 2008

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7610369

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab.

AFFILIATION: Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am J Hematol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab Related Publications

• 4 x 1204 holographic switching with an optically addressed spatial light modulator.
• Comparison of the toxicity of p-dichlorobenzene (p-DCB) administered to male F344 rats orally or by the inhalation route.
• Compartmentalized regulations of ion channels in the heart.
• Coordinated peripheral neuronal activities among the different regions of the digestive tract in aplysia.
• Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
• Disseminated adenovirus disease by multiple adenovirus serotypes following allogeneic hematopoietic stem cell transplantation.
• Extension of distance measurement range in a sinusoidal wavelength-scanning interferometer using a liquid-crystal wavelength filter with double feedback control.
• Eye-concentrated distribution of dexamethasone carried by sugar-chain modified liposome in experimental autoimmune uveoretinitis mice.
• FDG-PET in T-cell and NK-cell neoplasms.
• False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation.
• Immunohistochemical localization of T antigen-like substance in benign hyperplasia and adenocarcinoma of the prostate.
• Immunohistological detection of T antigen and ABH blood group antigens in upper urinary tract tumours.
• Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review).
• Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab.
• Long-term sustained mixed chimerism after allogeneic stem cell transplantation in a patient with severe aplastic anemia.
• Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9.
• Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
• Ranitidine: a pilot study in Japan.
• Synaptic potentials recorded in brain slices and their modification by changes in the level of tissue ATP.
• The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
• Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury.
• Ultrastructural changes associated with reversible and irreversible suppression of electrical activity in olfactory cortex slices.
• [Contact lenses with corrected inside curve. 3. Follow-up studies]
• [Human science. Sex. 4. Sexual and psychological maturity]
• [Median sternotomy in resection of bilateral multiple metastatic lung tumors]
• [The pathogenetic significance of deregulated hematopoietic transcription factors in leukemia]
• [Theoretical and clinical studies on a soft contact lens]
• [Theoretical and clinical studies on hydrophilic contact lenses. IX. Handling and storage of the lens]
• [Theoretical and clinical studies on soft contact lens. 5. Improvement of molecularly combined two-in-one lens]
• [Thrombocytopenia]